Clinical Question: Do treatments such as remdesivir or other anti-virals change patient outcomes in COVID-19 patients?
Bottom Line: To date, published RCTs have not demonstrated benefit of treating COVID-19 patients with remdesivir, lopinavir-ritonavir or oseltamivir. There are signals of potential benefits from one interim analysis of remdesivir and non-statistically different results, but more research is needed. Full publication of studies and ongoing trials will help to answer this question.
To read the full article, click here.